# SMOFLipid in Patients Who Are Intralipid Intolerant

> **NCT03054948** · PHASE4 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Home Parenteral Nutrition
- Short Bowel Syndrome

## Interventions

- **DRUG:** SMOFLipid
- **DRUG:** Standard therapy

## Key facts

- **NCT ID:** NCT03054948
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-02-01
- **Primary completion:** 2018-03-20
- **Final completion:** 2018-03-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Redesign of study protocol.
- **Last updated:** 2018-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03054948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03054948, "SMOFLipid in Patients Who Are Intralipid Intolerant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03054948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*